勘误：癌症进展与免疫治疗中的TNF悖论
Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy.
作者信息
Montfort Anne, Colacios Céline, Levade Thierry, Andrieu-Abadie Nathalie, Meyer Nicolas, Ségui Bruno
机构信息
INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Université Toulouse III - Paul Sabatier, Toulouse, France.
出版信息
Front Immunol. 2019 Oct 22;10:2515. doi: 10.3389/fimmu.2019.02515. eCollection 2019.
Abstract
[This corrects the article DOI: 10.3389/fimmu.2019.01818.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fimmu.2019.01818。]
相似文献
1
Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy.勘误：癌症进展与免疫治疗中的TNF悖论
Front Immunol. 2019 Oct 22;10:2515. doi: 10.3389/fimmu.2019.02515. eCollection 2019.
2
The TNF Paradox in Cancer Progression and Immunotherapy.癌症进展与免疫治疗中的肿瘤坏死因子悖论
Front Immunol. 2019 Jul 31;10:1818. doi: 10.3389/fimmu.2019.01818. eCollection 2019.
3
Corrigendum: modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.勘误：用抗PD-1和抗CTLA-4调节完整肿瘤片段会影响肿瘤浸润淋巴细胞的扩增和特异性。
Front Immunol. 2024 Jul 18;15:1462081. doi: 10.3389/fimmu.2024.1462081. eCollection 2024.
4
Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.勘误：使用3D微流控模型表征单核细胞在T细胞癌症免疫治疗中的作用。
Front Immunol. 2018 Jul 24;9:1719. doi: 10.3389/fimmu.2018.01719. eCollection 2018.
5
Corrigendum: Association of Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades.勘误：接受免疫检查点阻断治疗的黑色素瘤和非小细胞肺癌患者中突变与肿瘤突变负荷及预后的关联
Front Immunol. 2019 Jul 2;10:1523. doi: 10.3389/fimmu.2019.01523. eCollection 2019.
6
Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures.勘误：乳腺癌的免疫基因组图谱揭示了免疫治疗相关的基因特征。
Front Immunol. 2023 Jan 20;14:1134847. doi: 10.3389/fimmu.2023.1134847. eCollection 2023.
7
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.组蛋白甲基转移酶 Ezh2 控制肿瘤免疫治疗适应性耐药的机制。
Cell Rep. 2017 Jul 25;20(4):854-867. doi: 10.1016/j.celrep.2017.07.007.
8
Corrigendum: The Effect of High-Diet and Exercise Intervention on the TNF-α Level in Rat Spleen.勘误：高膳食与运动干预对大鼠脾脏肿瘤坏死因子-α水平的影响
Front Immunol. 2022 Mar 14;13:880142. doi: 10.3389/fimmu.2022.880142. eCollection 2022.
9
Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment.勘误：食管肿瘤微环境中的固有免疫细胞
Front Immunol. 2021 May 27;12:708705. doi: 10.3389/fimmu.2021.708705. eCollection 2021.
10
Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.勘误：基于CD1d不变自然杀伤T细胞的癌症免疫疗法：α-半乳糖神经酰胺及其他。
Front Immunol. 2018 Nov 20;9:2606. doi: 10.3389/fimmu.2018.02606. eCollection 2018.
引用本文的文献
1
VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study.A2058黑色素瘤细胞中VSIG-3/IGSF11基因沉默同时抑制黑色素瘤进展并诱导人T细胞产生抗肿瘤细胞因子谱：计算机模拟和体外研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3861-3880. doi: 10.1007/s00210-024-03491-z. Epub 2024 Oct 4.
Zotero 插件